It's an exciting time to be a rheumatologist

Brian F. Mandell, MD, PhD
Editor in Chief

In the past 5 years I have received honoraria for presenting CME talks funded by Abbott Laboratories and Wyeth, have utilized unrestricted institutional educational grants from Abbott and Amgen for educational programs, have been an investigator in a phase II clinical trial for Centocor, and am a member of the Abbott Rheumatology Clinical Scholar Program advisory board.

Brian F. Mandell, MD, PhD
Editor in Chief

In the past 5 years I have received honoraria for presenting CME talks funded by Abbott Laboratories and Wyeth, have utilized unrestricted institutional educational grants from Abbott and Amgen for educational programs, have been an investigator in a phase II clinical trial for Centocor, and am a member of the Abbott Rheumatology Clinical Scholar Program advisory board.

Brian F. Mandell, MD, PhD
Editor in Chief

In the past 5 years I have received honoraria for presenting CME talks funded by Abbott Laboratories and Wyeth, have utilized unrestricted institutional educational grants from Abbott and Amgen for educational programs, have been an investigator in a phase II clinical trial for Centocor, and am a member of the Abbott Rheumatology Clinical Scholar Program advisory board.